H Nawata

1.2k total citations
31 papers, 1.0k citations indexed

About

H Nawata is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, H Nawata has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Immunology. Recurrent topics in H Nawata's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). H Nawata is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Myeloid Leukemia Research (3 papers). H Nawata collaborates with scholars based in Japan and United States. H Nawata's co-authors include Taijiro Okabe, Toshihiko Yanase, Isao Ichino, Masatoshi Nomura, Masafumi Haji, Yoshihiro Nishi, Kiminobu Goto, MU Yi-ming, Koichi Oba and Masayuki Saito and has published in prestigious journals such as The Journal of Immunology, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

H Nawata

31 papers receiving 987 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Nawata Japan 12 540 204 189 184 153 31 1.0k
J.R. Puddefoot United Kingdom 20 453 0.8× 271 1.3× 91 0.5× 132 0.7× 450 2.9× 58 1.2k
Silvia Garibaldi Italy 18 251 0.5× 402 2.0× 79 0.4× 96 0.5× 273 1.8× 38 1.1k
Béatrice Jaspard‐Vinassa France 24 631 1.2× 89 0.4× 52 0.3× 59 0.3× 238 1.6× 35 1.3k
M. Vijay Kumar United States 21 541 1.0× 213 1.0× 65 0.3× 85 0.5× 208 1.4× 25 917
Satyanarayana Medicherla United States 20 556 1.0× 237 1.2× 43 0.2× 44 0.2× 96 0.6× 30 1.4k
David S. Loose‐Mitchell United States 14 326 0.6× 419 2.1× 61 0.3× 113 0.6× 112 0.7× 19 824
Earl Lawrence United States 12 733 1.4× 164 0.8× 226 1.2× 201 1.1× 29 0.2× 14 1.5k
Silvia Misiti Italy 25 619 1.1× 511 2.5× 104 0.6× 152 0.8× 523 3.4× 36 1.6k
Luisa Salvatori Italy 20 477 0.9× 174 0.9× 32 0.2× 97 0.5× 155 1.0× 33 1.1k
Michael E. Fant United States 23 504 0.9× 164 0.8× 60 0.3× 56 0.3× 203 1.3× 42 1.2k

Countries citing papers authored by H Nawata

Since Specialization
Citations

This map shows the geographic impact of H Nawata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Nawata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Nawata more than expected).

Fields of papers citing papers by H Nawata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Nawata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Nawata. The network helps show where H Nawata may publish in the future.

Co-authorship network of co-authors of H Nawata

This figure shows the co-authorship network connecting the top 25 collaborators of H Nawata. A scholar is included among the top collaborators of H Nawata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Nawata. H Nawata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda, Mitsuhiro, Yasuhiro Maeda, H Nawata, et al.. (2000). Establishment of a myelodysplastic syndrome (MDS)/secondary AML-derived T lymphoid cell line K2-MDS. Leukemia Research. 24(2). 103–108. 4 indexed citations
2.
Kimura, Rina, Hironori Yoshii, Masatoshi Nomura, et al.. (2000). Identification of Novel First Exons in Ad4BP/SF-1 (NR5A1) Gene and Their Tissue- and Species-Specific Usage. Biochemical and Biophysical Research Communications. 278(1). 63–71. 23 indexed citations
3.
Nawata, H, et al.. (2000). Transient eosinophilia by HIV infection. Annals of Hematology. 79(2). 99–101. 4 indexed citations
4.
Yanase, Toshihiko, et al.. (1999). Thiazolidinedione Induces Apoptosis and Monocytic Differentiation in the Promyelocytic Leukemia Cell Line HL60. Oncology. 57(Suppl. 2). 17–26. 55 indexed citations
5.
Yanase, Toshihiko, et al.. (1998). Subcutaneous or visceral adipose tissue expression of the PPARγ gene is not altered in the fatty ( ) Zucker rat. Metabolism. 47(12). 1494–1498. 13 indexed citations
6.
Yonemitsu, Yoshikazu, et al.. (1998). Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection.. International Journal of Oncology. 12(4). 777–84. 6 indexed citations
7.
Hisatomi, Akitaka, et al.. (1997). Elevated L-kynurenine level and its normalization by prednisolone in a patient with eosinophilia-myalgia syndrome.. PubMed. 88(1). 11–7. 3 indexed citations
8.
Okabe, Takuya & H Nawata. (1996). [NGFI-B/nur77 family involved in T-cell apoptosis].. PubMed. 54(7). 1768–72. 2 indexed citations
10.
Satō, Hiroshi, Takashi Negishi, A. Okamoto, et al.. (1996). Isolation and Characterization of the Human Chromosomal Gene for Prostacyclin-Stimulating Factor. The Journal of Biochemistry. 120(5). 929–933. 5 indexed citations
11.
Inoguchi, Toyoshi, et al.. (1995). Inhibition of Intercellular Communication via Gap Junction in Cultured Aortic Endothelial Cells by Elevated Glucose and Phorbol Ester. Biochemical and Biophysical Research Communications. 208(2). 492–497. 45 indexed citations
12.
Enjoji, Munechika, et al.. (1995). IgH Intronic Enhancer Element HE2 (μB) Functions as a cis‐Activator in Choroid Plexus Cells at the Cellular Level as well as in Transgenic Mice. Journal of Neurochemistry. 64(3). 961–966. 9 indexed citations
13.
Okabe, Taijiro, R. Takayanagi, Kyosuke Imasaki, et al.. (1995). cDNA cloning of a NGFI-B/nur77-related transcription factor from an apoptotic human T cell line.. The Journal of Immunology. 154(8). 3871–3879. 37 indexed citations
14.
Nishimura, Junji, et al.. (1993). Double t(1;7)(p36;p11) in a megakaryocytic crisis of chronic myelogenous leukemia with variant t(5;9;22). Cancer Genetics and Cytogenetics. 65(2). 107–110. 5 indexed citations
15.
Takatsuki, Hiroshi, et al.. (1993). Recurrent appearance of 14q+ chromosome associated with lymphoid crisis of Ph-positive chronic myelogenous leukemia. Cancer Genetics and Cytogenetics. 66(2). 103–107. 2 indexed citations
16.
Umemura, Tsukuru, et al.. (1992). Analysis of clonality at the level of progenitors in chronic myelogenous leukemia using the polymerase chain reaction. Leukemia Research. 16(4). 371–377. 9 indexed citations
17.
Takayanagi, Ryoichi, Keizo Ohnaka, Yoshiyuki Sakai, et al.. (1992). Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochemical and Biophysical Research Communications. 183(2). 910–916. 95 indexed citations
18.
Nakao, Ryo, Masafumi Haji, Toshihiko Yanase, et al.. (1992). A single amino acid substitution (Met786----Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome.. The Journal of Clinical Endocrinology & Metabolism. 74(5). 1152–1157. 43 indexed citations
19.
Shibata, Keisuke, Junji Nishimura, Yuji Yufu, & H Nawata. (1992). Alterations in thrombin-induced protein tyrosine phosphorylation of platelets from patients with chronic myelogenous leukemia.. PubMed. 55(2). 189–96. 5 indexed citations
20.
Takahira, Hiroyuki, et al.. (1989). Lymphoid Blast Crisis in a Patient with Philadelphia-Chromosome-Negative Chronic Myelocytic Leukemia. Acta Haematologica. 81(3). 155–159. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026